Search results
Adaptimmune (ADAP) Down on End of Collaboration With Roche
Zacks via Yahoo Finance· 1 month agoAdaptimmune Therapeutics plc ADAP announced that its strategic collaboration with Roche’s RHHBY...
Adaptimmune (ADAP) Rises as GSK Transfers T-Cell Therapy IND
Zacks via Yahoo Finance· 6 months agoAdaptimmune (ADAP) shares rise as GSK transfers IND for letetresgene autoluecel (lete-cel), which is...
News Flash: Analysts Just Made A Huge Upgrade To Their Adaptimmune Therapeutics plc (NASDAQ:ADAP)...
Simply Wall St. via Yahoo Finance· 1 year agoAdaptimmune Therapeutics plc (NASDAQ:ADAP) shareholders will have a reason to smile today, with the...
Adaptimmune (ADAP) Up 7%, Gets T-Cell Programs Rights From GSK
Zacks via Yahoo Finance· 1 year agoAdaptimmune Therapeutics (ADAP) enters into a transition deal with GSK to regain rights to its...
Is Adaptimmune Therapeutics (NASDAQ:ADAP) In A Good Position To Invest In Growth?
Simply Wall St. via Yahoo Finance· 1 year agoWe can readily understand why investors are attracted to unprofitable companies. For example,...
Mesa Labs and Eldorado Gold have been highlighted as Zacks Bull and Bear of the Day
Zacks via Yahoo Finance· 1 year agoFor Immediate Release Chicago, IL – December 28, 2022 – Zacks Equity Research shares Mesa Labs MLAB...
Why Adaptimmune Therapeutics Stock Is Glowing Green Today
Motley Fool· 2 years agoShares of the anti-cancer cell therapy company Adaptimmune Therapeutics (NASDAQ: ADAP) are having an...
Zacks.com featured highlights Sweetgreen, Adaptimmune Therapeutics, Owl Rock Capital, MACOM...
Zacks via Yahoo Finance· 1 year agoSweetgreen, Adaptimmune Therapeutics, Owl Rock Capital, MACOM Technology Solutions and Equity...
Got $500? 3 Absurdly Cheap Healthcare Stocks That Are Set to Skyrocket
Motley Fool· 2 years agoThere are some incredible deals in biotech right now. Three Fool.com contributors think Adaptimmune Therapeutics (NASDAQ: ADAP), G1 Therapeutics (NASDAQ: GTHX), and Axsome Therapeutics (NASDAQ ...
Kintara (KTRA) Rises 41% on $2M Grant for Breast Cancer Therapy
Zacks via Yahoo Finance· 11 months agoKintara (KTRA) receives a $2 million grant from the National Institutes of Health to develop its...
